Waters Corporation WAT
433.54
3.24
0.75%
as of 25 Sep
- Market cap
- $42.3B
- P/E
- 108×
Follow WAT
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Waters Corporation (WAT) Book value per share
Waters Corporation's book value per share at the end of fiscal 2025 was 43.0×, up 39.7% from 30.8× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 155×. Over the past ten years it has ranged from −3.2× (fiscal 2019) to 43.0× (fiscal 2025) — the current reading is the highest in ten years. Waters Corporation ranks 1st of 52 Diagnostics & Research companies by book value per share.
Book value per share, annual
Annual
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 43.0× | 39.66% |
| FY2024 | 30.8× | 58.27% |
| FY2023 | 19.5× | 131.53% |
| FY2022 | 8.4× | 40.89% |
| FY2021 | 6.0× | 59.66% |
| FY2020 | 3.7× | — |
| FY2019 | −3.2× | — |
| FY2018 | 20.4× | (27.29%) |
| FY2017 | 28.0× | (1.75%) |
| FY2016 | 28.5× | 13.95% |
Quarterly
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 155× | (16.89%) |
| Mar 2026 | 186× | 332.43% |
| Dec 2025 | 43.1× | 9.96% |
| Sep 2025 | 39.2× | 7.89% |
| 42 more quarters | Free account |
Against its own ten years
Low −3.2×
High 43.0×
Ten-year median
20.4×
Current reading's percentile
100
Book value per share against peers
| Company | Book value per share |
|---|---|
| WAT Waters Corporation | 155× |
| DGX Quest Diagnostics Incorporated compare | 70.4× |
| IQV IQVIA Holdings Inc. compare | 37.9× |
| A Agilent Technologies, Inc. compare | 26.1× |
| IDXX IDEXX Laboratories, Inc. compare | 20.4× |
| ILMN Illumina, Inc. compare | 18.8× |
| NTRA Natera, Inc. compare | 12.7× |
| MTD Mettler-Toledo International, Inc. compare | 0.6× |
| GH Guardant Health, Inc. compare | −1.7× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on WAT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- The full statement